Chronic Kidney Disease Drugs Market Size & Share Report 2034
Chronic Kidney Disease Drugs Market By Drug Class (Angiotensin-Converting Enzyme (ACE) Inhibitors, B-blockers, Angiotensin Receptor Blockers (ARBs), Loop Diuretics, Phosphate Binders, Erythropoiesis -Stimulating Agents, Calcium Channel Blockers, and Others), By Route of Administration (Parenteral and Oral), By Indication (Polycystic Kidney Disease, Hypertensive Neuropathy, Glomerulonephritis, Diabetic Neuropathy, and Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 213 Report Code: ZMR-10333
Published Date: Feb-2026 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 14.82 Billion | USD 23.80 Billion | 4.23% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Chronic Kidney Disease Drugs Market, (2025 - 2034) (USD Billion)
- 2.2 Global Chronic Kidney Disease Drugs Market : snapshot
- Chapter 3. Global Chronic Kidney Disease Drugs Market - Industry Analysis
- 3.1 Chronic Kidney Disease Drugs Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising patient awareness and focus on early CKD detection to offer improved revenue in the industry
- 3.3 Market Restraints
- 3.3.1. Stringent regulatory hurdles limit the chronic kidney disease market growth rate
- 3.4 Market Opportunities
- 3.4.1. Novel drug development to offer significant growth opportunities to the industry players
- 3.5 Market Challenges
- 3.5.1. Challenges will the high cost of R&D create for chronic kidney disease drug market players
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Class
- 3.7.2 Market attractiveness analysis By Route of Administration
- 3.7.3 Market attractiveness analysis By Indication
- 3.7.4 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Chronic Kidney Disease Drugs Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Chronic Kidney Disease Drugs Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Chronic Kidney Disease Drugs Market - Drug Class Analysis
- 5.1 Global Chronic Kidney Disease Drugs Market overview: By Drug Class
- 5.1.1 Global Chronic Kidney Disease Drugs Market share, By Drug Class, 2024 and 2034
- 5.2 Angiotensin-Converting Enzyme (ACE) Inhibitors
- 5.2.1 Global Chronic Kidney Disease Drugs Market by Angiotensin-Converting Enzyme (ACE) Inhibitors, 2025 - 2034 (USD Billion)
- 5.3 B-blockers
- 5.3.1 Global Chronic Kidney Disease Drugs Market by B-blockers, 2025 - 2034 (USD Billion)
- 5.4 Angiotensin Receptor Blockers (ARBs)
- 5.4.1 Global Chronic Kidney Disease Drugs Market by Angiotensin Receptor Blockers (ARBs), 2025 - 2034 (USD Billion)
- 5.5 Loop Diuretics
- 5.5.1 Global Chronic Kidney Disease Drugs Market by Loop Diuretics, 2025 - 2034 (USD Billion)
- 5.6 Phosphate Binders
- 5.6.1 Global Chronic Kidney Disease Drugs Market by Phosphate Binders, 2025 - 2034 (USD Billion)
- 5.7 Erythropoiesis -Stimulating Agents
- 5.7.1 Global Chronic Kidney Disease Drugs Market by Erythropoiesis -Stimulating Agents, 2025 - 2034 (USD Billion)
- 5.8 Calcium Channel Blockers
- 5.8.1 Global Chronic Kidney Disease Drugs Market by Calcium Channel Blockers, 2025 - 2034 (USD Billion)
- 5.9 Others
- 5.9.1 Global Chronic Kidney Disease Drugs Market by Others, 2025 - 2034 (USD Billion)
- 5.1 Global Chronic Kidney Disease Drugs Market overview: By Drug Class
- Chapter 6. Global Chronic Kidney Disease Drugs Market - Route of Administration Analysis
- 6.1 Global Chronic Kidney Disease Drugs Market overview: By Route of Administration
- 6.1.1 Global Chronic Kidney Disease Drugs Market share, By Route of Administration, 2024 and 2034
- 6.2 Parenteral
- 6.2.1 Global Chronic Kidney Disease Drugs Market by Parenteral, 2025 - 2034 (USD Billion)
- 6.3 Oral
- 6.3.1 Global Chronic Kidney Disease Drugs Market by Oral, 2025 - 2034 (USD Billion)
- 6.1 Global Chronic Kidney Disease Drugs Market overview: By Route of Administration
- Chapter 7. Global Chronic Kidney Disease Drugs Market - Indication Analysis
- 7.1 Global Chronic Kidney Disease Drugs Market overview: By Indication
- 7.1.1 Global Chronic Kidney Disease Drugs Market share, By Indication, 2024 and 2034
- 7.2 Polycystic Kidney Disease
- 7.2.1 Global Chronic Kidney Disease Drugs Market by Polycystic Kidney Disease, 2025 - 2034 (USD Billion)
- 7.3 Hypertensive Neuropathy
- 7.3.1 Global Chronic Kidney Disease Drugs Market by Hypertensive Neuropathy, 2025 - 2034 (USD Billion)
- 7.4 Glomerulonephritis
- 7.4.1 Global Chronic Kidney Disease Drugs Market by Glomerulonephritis, 2025 - 2034 (USD Billion)
- 7.5 Diabetic Neuropathy
- 7.5.1 Global Chronic Kidney Disease Drugs Market by Diabetic Neuropathy, 2025 - 2034 (USD Billion)
- 7.6 Others
- 7.6.1 Global Chronic Kidney Disease Drugs Market by Others, 2025 - 2034 (USD Billion)
- 7.1 Global Chronic Kidney Disease Drugs Market overview: By Indication
- Chapter 8. Global Chronic Kidney Disease Drugs Market - Distribution Channel Analysis
- 8.1 Global Chronic Kidney Disease Drugs Market overview: By Distribution Channel
- 8.1.1 Global Chronic Kidney Disease Drugs Market share, By Distribution Channel, 2024 and 2034
- 8.2 Online Pharmacies
- 8.2.1 Global Chronic Kidney Disease Drugs Market by Online Pharmacies, 2025 - 2034 (USD Billion)
- 8.3 Retail Pharmacies
- 8.3.1 Global Chronic Kidney Disease Drugs Market by Retail Pharmacies, 2025 - 2034 (USD Billion)
- 8.4 Hospital Pharmacies
- 8.4.1 Global Chronic Kidney Disease Drugs Market by Hospital Pharmacies, 2025 - 2034 (USD Billion)
- 8.1 Global Chronic Kidney Disease Drugs Market overview: By Distribution Channel
- Chapter 9. Chronic Kidney Disease Drugs Market - Regional Analysis
- 9.1 Global Chronic Kidney Disease Drugs Market Regional Overview
- 9.2 Global Chronic Kidney Disease Drugs Market Share, by Region, 2024 & 2034 (USD Billion)
- 9.3. North America
- 9.3.1 North America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.3.1.1 North America Chronic Kidney Disease Drugs Market, by Country, 2025 - 2034 (USD Billion)
- 9.3.1 North America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4 North America Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034
- 9.4.1 North America Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034 (USD Billion)
- 9.5 North America Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034
- 9.5.1 North America Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 9.6 North America Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034
- 9.6.1 North America Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034 (USD Billion)
- 9.7 North America Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034
- 9.7.1 North America Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4.2.1 Europe Chronic Kidney Disease Drugs Market, by Country, 2025 - 2034 (USD Billion)
- 9.4.2 Europe Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4 Europe Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034
- 9.4.1 Europe Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034 (USD Billion)
- 9.5 Europe Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034
- 9.5.1 Europe Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 9.6 Europe Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034
- 9.6.1 Europe Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034 (USD Billion)
- 9.7 Europe Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034
- 9.7.1 Europe Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.5.3.1 Asia Pacific Chronic Kidney Disease Drugs Market, by Country, 2025 - 2034 (USD Billion)
- 9.5.3 Asia Pacific Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4 Asia Pacific Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034
- 9.4.1 Asia Pacific Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034 (USD Billion)
- 9.5 Asia Pacific Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034
- 9.5.1 Asia Pacific Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 9.6 Asia Pacific Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034
- 9.6.1 Asia Pacific Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034 (USD Billion)
- 9.7 Asia Pacific Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034
- 9.7.1 Asia Pacific Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.6.4.1 Latin America Chronic Kidney Disease Drugs Market, by Country, 2025 - 2034 (USD Billion)
- 9.6.4 Latin America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4 Latin America Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034
- 9.4.1 Latin America Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034 (USD Billion)
- 9.5 Latin America Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034
- 9.5.1 Latin America Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 9.6 Latin America Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034
- 9.6.1 Latin America Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034 (USD Billion)
- 9.7 Latin America Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034
- 9.7.1 Latin America Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Country, 2025 - 2034 (USD Billion)
- 9.7.5 The Middle-East and Africa Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 9.4 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034
- 9.4.1 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Drug Class, 2025 - 2034 (USD Billion)
- 9.5 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034
- 9.5.1 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 9.6 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034
- 9.6.1 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Indication, 2025 - 2034 (USD Billion)
- 9.7 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034
- 9.7.1 The Middle-East and Africa Chronic Kidney Disease Drugs Market, by Distribution Channel, 2025 - 2034 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Boehringer Ingelheim
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 AstraZeneca
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Novartis
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Merck & Co.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Sanofi
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Takeda Pharmaceutical
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Roche
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Johnson & Johnson
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 AbbVie
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 GlaxoSmithKline
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Pfizer
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Eli Lilly
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Bristol Myers Squibb
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Bayer
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Amgen
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 and others.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Boehringer Ingelheim
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Chronic Kidney Disease Drugs Market attractiveness, By Drug Class
- 6. Global Chronic Kidney Disease Drugs Market attractiveness, By Route of Administration
- 7. Global Chronic Kidney Disease Drugs Market attractiveness, By Indication
- 8. Global Chronic Kidney Disease Drugs Market attractiveness, By Distribution Channel
- 9. Global Chronic Kidney Disease Drugs Market share by Drug Class, 2025 and 2034 (USD Billion)
- 10. Global Chronic Kidney Disease Drugs Market by Angiotensin-Converting Enzyme (ACE) Inhibitors, 2025 - 2034 (USD Billion)
- 11. Global Chronic Kidney Disease Drugs Market by B-blockers, 2025 - 2034 (USD Billion)
- 12. Global Chronic Kidney Disease Drugs Market by Angiotensin Receptor Blockers (ARBs), 2025 - 2034 (USD Billion)
- 13. Global Chronic Kidney Disease Drugs Market by Loop Diuretics, 2025 - 2034 (USD Billion)
- 14. Global Chronic Kidney Disease Drugs Market by Phosphate Binders, 2025 - 2034 (USD Billion)
- 15. Global Chronic Kidney Disease Drugs Market by Erythropoiesis -Stimulating Agents, 2025 - 2034 (USD Billion)
- 16. Global Chronic Kidney Disease Drugs Market by Calcium Channel Blockers, 2025 - 2034 (USD Billion)
- 17. Global Chronic Kidney Disease Drugs Market by Others, 2025 - 2034 (USD Billion)
- 18. Global Chronic Kidney Disease Drugs Market share by Route of Administration, 2025 and 2034 (USD Billion)
- 19. Global Chronic Kidney Disease Drugs Market by Parenteral, 2025 - 2034 (USD Billion)
- 20. Global Chronic Kidney Disease Drugs Market by Oral, 2025 - 2034 (USD Billion)
- 21. Global Chronic Kidney Disease Drugs Market share by Indication, 2025 and 2034 (USD Billion)
- 22. Global Chronic Kidney Disease Drugs Market by Polycystic Kidney Disease, 2025 - 2034 (USD Billion)
- 23. Global Chronic Kidney Disease Drugs Market by Hypertensive Neuropathy, 2025 - 2034 (USD Billion)
- 24. Global Chronic Kidney Disease Drugs Market by Glomerulonephritis, 2025 - 2034 (USD Billion)
- 25. Global Chronic Kidney Disease Drugs Market by Diabetic Neuropathy, 2025 - 2034 (USD Billion)
- 26. Global Chronic Kidney Disease Drugs Market by Others, 2025 - 2034 (USD Billion)
- 27. Global Chronic Kidney Disease Drugs Market share by Distribution Channel, 2025 and 2034 (USD Billion)
- 28. Global Chronic Kidney Disease Drugs Market by Online Pharmacies, 2025 - 2034 (USD Billion)
- 29. Global Chronic Kidney Disease Drugs Market by Retail Pharmacies, 2025 - 2034 (USD Billion)
- 30. Global Chronic Kidney Disease Drugs Market by Hospital Pharmacies, 2025 - 2034 (USD Billion)
- 31. Global Chronic Kidney Disease Drugs Market share, by Region, 2025 and 2034
- 32. North America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 33. Europe Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 34. Asia Pacific Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 35. Latin America Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
- 36. The Middle-East and Africa Chronic Kidney Disease Drugs Market, 2025 - 2034 (USD Billion)
Table Of Tables
- 1. Global Chronic Kidney Disease Drugs Market: Snapshot
- 2. Drivers of the Chronic Kidney Disease Drugs Market: impact analysis
- 3. North America Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 4. North America Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 5. North America Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 6. North America Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 7. U.S. Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 8. U.S. Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 9. U.S. Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 10. U.S. Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 11. Canada Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 12. Canada Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 13. Canada Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 14. Canada Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 15. Europe Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 16. Europe Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 17. Europe Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 18. Europe Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 19. Germany Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 20. Germany Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 21. Germany Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 22. Germany Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 23. France Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 24. France Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 25. France Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 26. France Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 27. U.K. Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 28. U.K. Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 29. U.K. Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 30. U.K. Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 31. Italy Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 32. Italy Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 33. Italy Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 34. Italy Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 35. Spain Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 36. Spain Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 37. Spain Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 38. Spain Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 39. Rest of Europe Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 40. Rest of Europe Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 41. Rest of Europe Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 42. Rest of Europe Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 43. Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 44. Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 45. Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 46. Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 47. China Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 48. China Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 49. China Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 50. China Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 51. Japan Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 52. Japan Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 53. Japan Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 54. Japan Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 55. India Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 56. India Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 57. India Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 58. India Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 59. South Korea Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 60. South Korea Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 61. South Korea Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 62. South Korea Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 63. South-East Asia Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 64. South-East Asia Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 65. South-East Asia Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 66. South-East Asia Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 67. Rest of Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 68. Rest of Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 69. Rest of Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 70. Rest of Asia Pacific Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 71. Latin America Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 72. Latin America Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 73. Latin America Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 74. Latin America Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 75. Brazil Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 76. Brazil Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 77. Brazil Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 78. Brazil Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 79. Mexico Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 80. Mexico Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 81. Mexico Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 82. Mexico Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 83. Rest of Latin America Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 84. Rest of Latin America Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 85. Rest of Latin America Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 86. Rest of Latin America Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 87. The Middle-East and Africa Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 88. The Middle-East and Africa Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 89. The Middle-East and Africa Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 90. The Middle-East and Africa Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 91. GCC Countries Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 92. GCC Countries Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 93. GCC Countries Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 94. GCC Countries Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 95. South Africa Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 96. South Africa Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 97. South Africa Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 98. South Africa Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
- 99. Rest of Middle-East Africa Chronic Kidney Disease Drugs Market revenue, By Drug Class, 2025 - 2034 (USD Billion)
- 100. Rest of Middle-East Africa Chronic Kidney Disease Drugs Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 101. Rest of Middle-East Africa Chronic Kidney Disease Drugs Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 102. Rest of Middle-East Africa Chronic Kidney Disease Drugs Market revenue, By Distribution Channel, 2025 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Chronic kidney disease (CKD) drugs are medicines specially designed to treat medical conditions related to the kidney.
The global chronic kidney disease drugs market is expected to be driven by the growing number of diabetic patients across the globe.
According to study, the global chronic kidney disease drugs market size was worth around USD 14.82 billion in 2024 and is predicted to grow to around USD 23.80 billion by 2034.
The CAGR value of the chronic kidney disease drugs market is expected to be around 4.23% during 2025-2034.
The global chronic kidney disease drugs industry is projected to be challenged by the high cost of R&D associated with the market.
Use of advanced technology during R&D and precision medicine is the emerging trend and innovation impacting the chronic kidney disease drugs market.
The global chronic kidney disease drugs market has performed well so far and will continue the same trend in the coming years.
The global chronic kidney disease drugs market is expected to be dominated by North America during the projection period.
The global chronic kidney disease drugs market is led by players like Boehringer Ingelheim, AstraZeneca, Novartis, Merck & Co., Sanofi, Takeda Pharmaceutical, Roche, Johnson & Johnson, AbbVie, GlaxoSmithKline, Pfizer, Eli Lilly, Bristol Myers Squibb, Bayer, and Amgen.
The report explores crucial aspects of the chronic kidney disease drugs market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
